BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16039223)

  • 1. Long-term incidence of arrhythmias in extracardiac conduit Fontan and comparison between systemic left and right ventricle.
    Di Mambro C; Yammine ML; Tamborrino PP; Giordano U; Righi D; Unolt M; Cantarutti N; Maiolo S; Albanese S; Carotti A; Amodeo A; Galletti L; Drago F
    Europace; 2024 May; 26(5):. PubMed ID: 38650062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pacemaker-Related Factors and Outcomes of Fontan Patients - Impact of Paced QRS Duration.
    Shin H; Baek JS; Kim MJ; Cha S; Yu JJ
    Circ J; 2024 Apr; 88(5):642-648. PubMed ID: 38267052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmias and the extracardiac conduit Fontan: promise unfulfilled?
    Balaji S; Etheridge SP
    Europace; 2024 Mar; 26(4):. PubMed ID: 38650056
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic anticoagulation following the Fontan operation.
    Walker HA; Gatzoulis MA
    Heart; 2005 Jul; 91(7):854-6. PubMed ID: 15958342
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of occult thrombosis in individuals with Fontan circulation by cardiac MRI.
    Curtis SF; Cicioni M; Mullikin A; Williams J; Campbell JM; Barker PCA; McCrary AW
    Cardiol Young; 2024 Mar; ():1-6. PubMed ID: 38506050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Hemodynamic Performance of Fontan Operation for Glenn Physiology using Computational Fluid Dynamics: Ten Patient-specific Cases.
    Javadi E; Laudenschlager S; Kheyfets V; Di Maria M; Stone M; Jamali S; Powell AJ; Moghari MH
    J Clin Images Med Case Rep; 2022 Jun; 3(6):. PubMed ID: 36339935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application for Tissue Engineering Focused on Materials.
    Kitsuka T; Hama R; Ulziibayar A; Matsuzaki Y; Kelly J; Shinoka T
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration of the Pathological Features of Pediatric Congenital Heart Diseases Which Are Ideally Suitable for Diagnosing With Multidetector-row CT.
    Hayabuchi Y; Inoue M; Watanabe N; Sakata M; Ohnishi T; Kagami S
    Cardiol Res; 2011 Aug; 2(4):150-159. PubMed ID: 28352384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.
    Gnanappa GK; Celermajer DS; Sholler GF; Gentles T; Winlaw D; d'Udekem Y; Ayer J
    Pediatr Cardiol; 2017 Jan; 38(1):56-69. PubMed ID: 27787594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-Term Results After Extracardiac Conduit Fontan Palliation in Children and Young Adults with Single Ventricle Physiology-A Single-center Experience.
    Raj S; Rosenkranz E; Sears B; Swaminathan S
    Pediatr Cardiol; 2016 Aug; 37(6):1111-8. PubMed ID: 27160098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical planning of the total cavopulmonary connection: robustness analysis.
    Restrepo M; Luffel M; Sebring J; Kanter K; Del Nido P; Veneziani A; Rossignac J; Yoganathan A
    Ann Biomed Eng; 2015 Jun; 43(6):1321-34. PubMed ID: 25316591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fontan pathway growth: a quantitative evaluation of lateral tunnel and extracardiac cavopulmonary connections using serial cardiac magnetic resonance.
    Restrepo M; Mirabella L; Tang E; Haggerty CM; Khiabani RH; Fynn-Thompson F; Valente AM; McElhinney DB; Fogel MA; Yoganathan AP
    Ann Thorac Surg; 2014 Mar; 97(3):916-22. PubMed ID: 24444876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.
    Patterson JT; Gilliland T; Maxfield MW; Church S; Naito Y; Shinoka T; Breuer CK
    Regen Med; 2012 May; 7(3):409-19. PubMed ID: 22594331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Center variation in patient age and weight at Fontan operation and impact on postoperative outcomes.
    Wallace MC; Jaggers J; Li JS; Jacobs ML; Jacobs JP; Benjamin DK; O'Brien SM; Peterson ED; Smith PB; Pasquali SK
    Ann Thorac Surg; 2011 May; 91(5):1445-52. PubMed ID: 21524453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation.
    Friedman KG; Salvin JW; Wypij D; Gurmu Y; Bacha EA; Brown DW; Laussen PC; Scheurer MA
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):1000-6. PubMed ID: 21377892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of size of secondary ventricles to exercise performance in children after fontan operation.
    Prakash A; Travison TG; Fogel MA; Hurwitz LM; Powell AJ; Printz BF; Puchalski MD; Shirali GS; Yoo SJ; Geva T;
    Am J Cardiol; 2010 Dec; 106(11):1652-6. PubMed ID: 21094369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet versus anticoagulation therapy after extracardiac conduit Fontan: a systematic review and meta-analysis.
    Marrone C; Galasso G; Piccolo R; de Leva F; Paladini R; Piscione F; Santoro G
    Pediatr Cardiol; 2011 Jan; 32(1):32-9. PubMed ID: 20967441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific issues after extracardiac fontan operation: ventricular function, growth potential, arrhythmia, and thromboembolism.
    Chowdhury UK; Airan B; Kothari SS; Talwar S; Saxena A; Singh R; Subramaniam GK; Pradeep KK; Patel CD; Venugopal P
    Ann Thorac Surg; 2005 Aug; 80(2):665-72. PubMed ID: 16039223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of 200 patients after an extracardiac Fontan procedure.
    Kim SJ; Kim WH; Lim HG; Lee JY
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):108-16. PubMed ID: 18603062
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.